---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-008982"
form_type: "8-K"
ticker: "BNKK"
cik: "0001760903"
company_name: "BONK, INC."
filed_at: "2025-03-04T23:59:59+00:00"
generated_at: "2026-05-25T14:46:39.104513+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Safety Shot publishes peer-reviewed trial showing rapid alcohol reduction and hangover prevention

## Summary
- Randomized, double-blind, placebo-controlled crossover study published in Journal of Nutrition and Dietary Supplements (Volume 17, Pages 43-62).
- Safety Shot significantly reduced blood and breath alcohol levels at 30-240 minutes post-consumption (p<0.05).
- Increased aldehyde dehydrogenase (AUC and Cmax both p<0.01), suggesting faster alcohol metabolism.
- Participants reported less head discomfort, fatigue, and improved concentration vs placebo.
- Company cites global hangover cure market projected to reach over $6B by 2032 at 14.1% CAGR.

## SEC filing metadata
- accession: 0001493152-25-008982
- form_type: 8-K
- ticker: BNKK
- cik: 0001760903
- company_name: BONK, INC.
- filed_at: 2025-03-04T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1760903/000149315225008982/0001493152-25-008982-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1760903/000149315225008982/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-008982
- JSON: https://secwatch.observer/filing/0001493152-25-008982.json
- Plain text: https://secwatch.observer/filing/0001493152-25-008982.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.